Shorts

EHA 2026 Highlights Include Advances in Pediatric ALL, Immunotherapy: Shannon L. Maude, MD, PhD, and Martin Schrappe, MD, PhD

The Fundamental Immune Paradox of Cancer Therapy

Improving Clinical Thresholds for Patient Health Outcomes: Samuel Shangwu Wu, PhD

Can Oral Ketones Treat Diabetic Heart Failure?: Anne Komé, PharmD

Better Early-Onset CRC Survivorship Care Hinges on Cardiometabolic Risk Understanding: Meng-Han Tsai, PhD

Why Visceral Fat Loss Matters More Than Muscle: Lee Kaplan, MD, PhD

Inhaled Insulin a Game Changer for Kids With Needle Phobia

The Value of Vaccine Co-Administration: Jamie R. Felzer, MD

3 Common Vaccine Myths Debunked by an Expert: Jamie R. Felzer, MD

Active vs Passive Outreach for Hepatitis B Reengagement: Helen Nde, MPH

Challenges of Diminishing Returns in CLL Treatment: Adam Kittai, MD

Efgartigimod Works Faster to Address the Symptoms of gMG: James F. Howard, MD

Cardio-Oncology Link Drives Focus on CVD Mortality in Patients With Early-Onset CRC: Meng-Han Tsai, PhD

Prevention Is Key to Avoiding Surgery After Retinal Detachment: Jonathan Jonisch, MD

The "Shared-Care" Model for Lung Disease: Yet Khor, MD, PhD

Existing Assessment Tools Could Strengthen Social Needs Identification Efforts: Jonathan Wrathall, PhD

Why Pulmonary Fibrosis Diagnosis Takes So Long: Yet Khor, MD, PhD

Focus Turns to Real-World Use, Access as Sparsentan Moves Into FSGS Care: Kirk Campbell, MD

Stop Using "One Size Fits All" for Pneumonia: Janet Lee, MD

Sparsentan Approval Marks Historic Step Forward for Patients With FSGS: Kirk Campbell, MD

Advocacy Is Not a Solo Endeavor: Rose Gerber, MS

Ensuring Treatment Access Remains Central Challenge in Lung Cancer Care: Deborah Doroshow, MD, PhD

Why Local Cancer Care Is in Crisis: Kathy Oubre, MS

History of Medicine Offers Lessons for Modern Cancer Care: Deborah Doroshow, MD, PhD

AJMC Research Roundup: April 2026

Study Finds Minimal Shifts in Primary Care Selection Following Benefit Design Changes: Tim McDonald, PhD, MPP

Consumer Inertia, Information Gaps Contribute to Inefficiency in Health Care Markets: Bryan E. Dowd, PhD

Efgartigimod Will Likely Be Used as Second-Line Treatment for oMG: Carolina Barnett-Tapia, MD, PhD

BCBSNC Foundation Reflects on 25 Years, Looks Ahead With Renewed Purpose: Katie Eyes, MSW

School Nurses Do Way More Than You Think: Shara Bialo, MD